Skip to main content
. 2015 Feb 26;45(3):185–208. doi: 10.3109/10408444.2014.1003423

Table 1.

Summary of toxicological endpoints for glyphosate (Germany Rapporteur Member State 2015c).

Endpoint Value Remark
Oral absorption ca 20% Rat, in vivo
Dermal absorption < 1% Human, in vitro,
0.015 g glyphosate/L
Rat LD50 oral > 2000 mg/kg bw  
Rat LD50 dermal > 2000 mg/kg bw  
Rat LC50 inhalation > 5 mg/L 4-h exposure
Skin irritation Not irritating  
Eye irritation Acid: moderately to severely irritating
Salts: slight or non-irritating
 
Skin sensitization Not sensitizing
(LLNA, Magnusson-Kligmant, and Buehler test)
 
Genotoxicity Not genotoxic (in vitro and in vivo)  
Chronic toxicity BW gain, liver (organ weight ↑, clinical chemistry, histology); salivary glands (organ weight ↑, histology); stomach mucosa and bladder epithelium(histology); eye (cataracts), caecum (distention, organ weight ↑)
NOAEL = 100 mg/kg bw/day (2-yr rat)
Critical study used for ADI setting
Reproductive toxicity Reduced pup weight at parentally toxic doses.
NOAEL = 300 mg/kg bw/day
 
Developmental toxicity Post-implantation loss, fetal BW & ossification ↓; effects confined to maternally toxic doses
Rat NOAEL: 300 mg/kg bw/day
Rabbit NOAEL: 50 mg/kg bw/day
 
Delayed neurotoxicity No relevant effects, NOAEL: 2000 mg/kg bw/day  
Acceptable Daily Intake (ADI) 0.5 mg/kg bw/day
Based on developmental toxicity in rabbits
Safety factor 100
Acceptable Operator Exposure Level (AOEL) 0.1 mg/kg bw/day
Based on maternal toxicity in rabbit teratogenicity study
Safety factor 100
Corrected for oral absorption of 20%